NCT07415538

Brief Summary

The aim of this randomized controlled study was to compare the effects of Mulligan SNAG added to conventional physiotherapy with conventional physiotherapy alone and sham SNAG on pain, function, proprioception, and functional performance in individuals with chronic nonspecific low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 10, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2026

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

1 month

First QC Date

February 10, 2026

Last Update Submit

February 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to mark their perceived level of low back pain. Higher scores will indicate greater pain intensity.

    6 weeks

Secondary Outcomes (5)

  • Lumbar Proprioception (Joint Position Sense Error)

    6 weeks

  • Functional Performance (Five Times Sit-to-Stand Test)

    6 weeks

  • Functional Disability (ODI)

    6 weeks

  • Kinesiophobia (Tampa Scale of Kinesiophobia)

    6 weeks

  • Global Rating of Change (GRC)

    At week 6 of the intervention

Study Arms (3)

Conventional Physiotherapy

EXPERIMENTAL
Other: Conventional Physiotherap

Conventional Physiotherapy + Mulligan SNAG

EXPERIMENTAL
Other: Conventional Physiotherapy + Mulligan SNAG

Conventional Physiotherapy + Sham SNAG

SHAM COMPARATOR
Other: Conventional Physiotherapy + Sham SNAG

Interventions

Participants in this arm received the same conventional physiotherapy program as the control group, combined with Mulligan Sustained Natural Apophyseal Glide (SNAG) techniques applied to the lumbar spine. SNAG techniques were performed by a physiotherapist during active pain-free movements, three times per week for six weeks.

Conventional Physiotherapy + Mulligan SNAG

Participants in this arm received a standardized conventional physiotherapy program consisting of electrotherapy, thermal modalities, stretching exercises, and core stabilization exercises. The program was administered three times per week for six weeks.

Conventional Physiotherapy

Participants in this arm received the standardized conventional physiotherapy program combined with sham SNAG applications. The sham procedure mimicked the positioning and therapist-patient interaction of the SNAG technique but without the application of therapeutic glide force. Interventions were administered three times per week for six weeks.

Conventional Physiotherapy + Sham SNAG

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged between 18 and 65 years
  • Presence of chronic nonspecific low back pain lasting for at least 6 months
  • No signs or symptoms of radicular pain or progressive neurological deficit
  • No history of lumbar spine surgery
  • No manual therapy, spinal injection, or structured physiotherapy program for low back pain within the last 3 months
  • Ability to participate in a physiotherapy and exercise program
  • Willingness to participate in the study and provision of written informed consent

You may not qualify if:

  • Specific causes of low back pain (e.g., fracture, tumor, infection, inflammatory spinal disorders)
  • Presence of radiculopathy or severe neurological impairment
  • History of spinal surgery
  • Pregnancy
  • Severe balance, vestibular, or neurological disorders that may interfere with proprioception testing
  • Any medical condition contraindicating physical therapy or manual therapy
  • Participation in another clinical trial or receiving concurrent treatment for low back pain during the intervention period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biruni University

Istanbul, Zeytinburnu, 34015, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 10, 2026

First Posted

February 17, 2026

Study Start

January 5, 2026

Primary Completion

February 13, 2026

Study Completion

February 20, 2026

Last Updated

March 2, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations